Fechtmeyer Phoebe H, Yeh Johannes T-H
Cold Spring Harbor Laboratory, Cold Spring Harbor NY 11724.
bioRxiv. 2024 Dec 7:2024.12.07.627262. doi: 10.1101/2024.12.07.627262.
Targeted protein degradation (TPD) is a promising new therapeutic modality that leverages the endogenous cellular protein degradation machinery of the ubiquitin-proteasome system (UPS) to degrade selected proteins. Recently, we developed a synthetic macrocycle ligand to recruit CUL3 E3 ligase for TPD. Using this KLHL20 ligand, we constructed the PROTAC BTR2004, which demonstrated potent degradation of BET family proteins BRD 2, 3, and 4. As the TPD field expands, it is important to understand the cellular and biochemical properties of all utilized E3 ligases. Herein we report the temporal and spatial processes of BTR2004-facilitated BET family protein degradation by KLHL20: The target protein degradation kinetics, BTR2004 intracellular activity half-life, and the onset of BTR2004 cell permeabilization. Employing proximity ligation and confocal microscopy techniques, we also illustrate the subcellular location of the ternary complex assembly upon BTR2004 treatment. These characterizations provide further insight into the processes that govern TPD and features that could be incorporated when designing future PROTAC molecules.
靶向蛋白质降解(TPD)是一种很有前景的新型治疗方式,它利用泛素-蛋白酶体系统(UPS)的内源性细胞蛋白质降解机制来降解特定蛋白质。最近,我们开发了一种合成大环配体,用于招募CUL3 E3连接酶以进行TPD。使用这种KLHL20配体,我们构建了PROTAC BTR2004,它能有效降解BET家族蛋白BRD 2、3和4。随着TPD领域的扩展,了解所有所利用的E3连接酶的细胞和生化特性很重要。在此我们报告了KLHL20促进BTR2004介导的BET家族蛋白降解的时间和空间过程:靶蛋白降解动力学、BTR2004细胞内活性半衰期以及BTR2004细胞通透性的起始。利用邻近连接和共聚焦显微镜技术,我们还展示了BTR2004处理后三元复合物组装的亚细胞定位。这些表征为调控TPD的过程以及设计未来PROTAC分子时可纳入的特征提供了进一步的见解。